Global edition
Region
NewsWebcastsPodcastsThe Magazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Microbiology & CCS
  • Pharma IT
  • Pharma Marketing
  • Regulatory Intelligence
  • Bio Pharma
  • Future Pharma Trends
Formats
  • News & Analysis
  • Interviews
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Home/News
NewsAI-assisted

Argon Medical Introduces CLEANER Vac™ Thrombectomy System To Clear Blood Clots

The CLEANER Vac Thrombectomy system offers efficient blood clot removal for Peripheral Vascular Disease.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Sep 17, 2024Updated Jun 26, 2025 · 2 min read
Share
Argon Medical Introduces CLEANER Vac™ Thrombectomy System To Clear Blood Clots
https://www.brydenpi.com/brand/argon-medical/
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

The CLEANER Vac Thrombectomy system, is a single-use, large bore suction device, that is designed for the efficient removal of blood clots from vessels with impaired circulation. This Thrombectomy system precisely enables physicians to control the clot removal process and minimise the risk of blood loss and damaging the blood vessel. 

CLEANER Vac is designed to chiefly cure Peripheral Vascular Disease(PVD), where the blood circulation gets blocked or narrowed due to deposition. Argon Medical Devices are one of the advancing manufacturers of medical devices for Vascular Surgery, Interventional Radiology, Oncology Procedures & Interventional Cardiology, that prioritises the productive results, efficacy and safety of patients. The CLEANER Vac Thrombectomy system justifies the commitment of Argon Medical to the healthcare industry.

Dr. Fakhir Elmasri, Interventional Radiologist and the 1st physician to use CLEANER Vac in the U.S for treating a patient, explained the efficacy of this Thrombectomy System by saying, “Removing thrombus from the venous anatomy can be very challenging depending on the patient's condition. Interventionalists need a simple and intuitive tool that allows them to easily navigate through the vasculature to the treatment area and control the removal of any obstructive thrombus. The streamlined design of the CLEANER Vac enables easy assembly, quick navigation, and efficient treatment, making it a welcomed treatment option for patients with this disease state.”

“Nearly 900,000 people in the United States are diagnosed with problematic blood clots in the venous system, every year, leading to between 60,000 and 100,000 deaths annually1. The CLEANER Vac Thrombectomy System offers physicians more control to remove those clots and the streamlined design can simplify traditionally complex procedures”, Tom Younkar, Senior Vice President of Global Marketing of Argon Medical stated. 

George Leondis, President & CEO of Argon Medical added, "We are committed to advancing healthcare and we are excited to deliver the newest thrombectomy solution to interventionalists who prioritise efficient, successful outcomes for their patients. The CLEANER Vac Thrombectomy System is a testament to our dedication to improving treatment for this disease state, and we are confident this device will easily integrate into the current standard of care.”

 

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

Trending now

1

Sanofi Appoints Archana Subramanya as Head of R&D India Hub

News · Aug 07, 2026
2

Kiora Pharmaceuticals Advances KIO-301 Phase 2 Enrollment Toward Coordinated Global Phase 3 Strategy

News · Aug 07, 2026
3

Emcure Pharma Reports 23% Revenue Rise to Rs 2,580 Crore in Q1 FY2026

News · Aug 07, 2026
4

FDA CBER OTP Convenes Town Hall on CMC Readiness Standards for Gene Therapy BLA Submissions

News · Aug 07, 2026
5

FDA Grants Accelerated Approval to Tudriqev for Anti-PD-1 Refractory Advanced Melanoma

News · Aug 07, 2026
The signal
The week in pharma, distilled

One considered email — the stories, moves and numbers that matter, every Friday.

More from Pharma News

All stories →
Sanofi Appoints Archana Subramanya as Head of R&D India Hub
News

Sanofi Appoints Archana Subramanya as Head of R&D India Hub

Vaibhavi M. · Aug 07, 2026
Kiora Pharmaceuticals Advances KIO-301 Phase 2 Enrollment Toward Coordinated Global Phase 3 Strategy
News

Kiora Pharmaceuticals Advances KIO-301 Phase 2 Enrollment Toward Coordinated Global Phase 3 Strategy

Vaibhavi M. · Aug 07, 2026
Emcure Pharma Reports 23% Revenue Rise to Rs 2,580 Crore in Q1 FY2026
News

Emcure Pharma Reports 23% Revenue Rise to Rs 2,580 Crore in Q1 FY2026

Pharma Now Editorial Team · Aug 07, 2026